Berachain vs Bio Protocol — how do they compare? Berachain trades at Rp2,536 (market cap Rp803,84M, Rp234,24M 24h volume), while Bio Protocol trades at Rp438.31 (market cap Rp997,34M, Rp163,74M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Berachain's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Berachain for 16 Days and Bio Protocol for 18 Days on average.
| BERA | BIO | |
|---|---|---|
Market Cap | Rp803,84M | Rp997,34M |
Volume (24h) | Rp234,24M | Rp163,74M |
Circulating Supply | 317M BERA | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 16 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
Berachain (BERA) is currently trading at Rp2,533 with a market cap of Rp804.4M, showing bearish technical signals across most indicators. The token faces significant selling pressure with moving averages indicating strong bearish momentum while oscillators remain neutral. Current price sits near the pivot point of Rp2,530 with immediate support at Rp2,494 and resistance at Rp2,572. Hold time of 16 days suggests relatively short-term holding patterns among investors.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in potential bounce from support levels, while major risks include continued selling pressure and limited fundamental developments. Investors should monitor for any ecosystem updates that could change the token's utility and adoption trajectory.
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
What Pluang investors did over the last 30 days
Berachain's PoL mechanism changes L1 economics by creating a marketplace for validators, users, and apps. Validators stake BERA to secure the network and earn BGT rewards, which they can use for application rewards. This system helps scale chain rewards based on demand for security and liquidity.
Read more on BERA →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →